Darell D Bigner Selected Research

Darell D Bigner Research Topics

Disease

142	Neoplasms (Cancer) 01/2021 - 01/2002
100	Glioma (Gliomas) 01/2022 - 01/2002
72	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2004
45	Brain Neoplasms (Brain Tumor) 01/2019 - 11/2002
13	Medulloblastoma 09/2017 - 07/2002
11	Melanoma (Melanoma, Malignant) 01/2021 - 01/2002
7	Lymphopenia (Lymphocytopenia) 06/2013 - 02/2008
6	Bites and Stings (Sting) 01/2022 - 07/2011
6	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2002
5	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2006
5	Carcinogenesis 01/2017 - 01/2011
4	Poliomyelitis (Polio) 01/2021 - 11/2014
4	Infections 01/2021 - 02/2009
4	Inflammation (Inflammations) 01/2021 - 11/2016
4	Hypersensitivity (Allergy) 03/2011 - 04/2009
4	Oligodendroglioma 12/2009 - 01/2006
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2018 - 08/2004
3	Hypoxia (Hypoxemia) 01/2016 - 08/2006
2	Disease Progression 01/2021 - 10/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 11/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 09/2014 - 09/2006

Drug/Important Bio-Agent (IBA)

43	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2002
40	epidermal growth factor receptor VIIIIBA 01/2019 - 01/2002
29	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2003
29	Monoclonal AntibodiesIBA 01/2016 - 01/2002
22	Temozolomide (Temodar)FDA LinkGeneric 01/2016 - 09/2002
20	AntigensIBA 01/2020 - 01/2002
16	Immunotoxins (Immunotoxin)IBA 01/2019 - 01/2005
16	VaccinesIBA 01/2018 - 02/2002
11	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019 - 02/2009
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2002
8	Pharmaceutical PreparationsIBA 01/2018 - 09/2007
8	Biological ProductsIBA 12/2013 - 05/2005
8	Peptides (Polypeptides)IBA 03/2013 - 01/2002
7	EnzymesIBA 01/2019 - 02/2006
7	Phosphotransferases (Kinase)IBA 12/2015 - 12/2004
7	Irinotecan (Camptosar)FDA LinkGeneric 06/2011 - 09/2002
7	O(6)-benzylguanineIBA 10/2009 - 05/2002
7	Carmustine (FIVB)FDA Link 08/2009 - 05/2002
6	MethyltransferasesIBA 01/2022 - 10/2005
6	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 05/2009
6	CytokinesIBA 01/2016 - 06/2004
6	Bevacizumab (Avastin)FDA Link 06/2011 - 08/2006
5	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 04/2013
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2009
5	Single-Chain AntibodiesIBA 01/2018 - 01/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 08/2006
5	D2C7-(scdsFv)-PE38KDELIBA 04/2017 - 09/2013
5	NADP (NADPH)IBA 01/2013 - 02/2009
5	N-succinimidyl 4-guanidinomethyl-3-iodobenzoateIBA 10/2010 - 01/2002
5	Alkyl and Aryl TransferasesIBA 02/2009 - 09/2002
5	Tyrosine Kinase InhibitorsIBA 11/2005 - 11/2002
4	poliovirus receptorIBA 01/2021 - 07/2004
4	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2011
4	RNA (Ribonucleic Acid)IBA 10/2015 - 03/2015
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 11/2002
4	isocitric acid (isocitrate)IBA 12/2012 - 02/2009
4	Oxidoreductases (Dehydrogenase)IBA 12/2012 - 02/2009
4	Cytotoxins (Cytolysins)IBA 01/2012 - 02/2007
4	Glycoproteins (Glycoprotein)IBA 07/2011 - 04/2006
4	TenascinIBA 05/2007 - 08/2004
4	Gefitinib (Iressa)FDA Link 02/2006 - 11/2002
3	Messenger RNA (mRNA)IBA 01/2018 - 04/2006
3	ProteomeIBA 01/2018 - 10/2009
3	ExotoxinsIBA 04/2017 - 10/2003
3	alpha-hydroxyglutarateIBA 01/2017 - 02/2011
3	Chimeric Antigen ReceptorsIBA 03/2016 - 01/2014
3	Tyrosine (L-Tyrosine)FDA Link 12/2015 - 06/2007
3	Antineoplastic Agents (Antineoplastics)IBA 12/2013 - 11/2012
3	GangliosidesIBA 09/2013 - 01/2010
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2013 - 02/2006
3	Amino Acids FDA Link 01/2013 - 04/2006
3	Protein Subunit VaccinesIBA 01/2013 - 02/2008
3	1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycolurilIBA 01/2012 - 05/2003
3	Human Serum Albumin FDA LinkGeneric 09/2011 - 02/2007
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2011 - 01/2005
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2009 - 05/2006
3	Transforming Growth Factor beta (TGF-beta)IBA 05/2009 - 06/2004
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	A-factor (Streptomyces)IBA 01/2019 - 01/2011
2	chondroitin sulfate proteoglycan 4IBA 01/2019 - 01/2017
2	Therapeutic UsesIBA 01/2018 - 08/2009
2	Formaldehyde (Formol)FDA Link 12/2017 - 01/2016
2	ParaffinIBA 12/2017 - 01/2016
2	AntibodiesIBA 01/2017 - 08/2010
2	ChemokinesIBA 11/2016 - 03/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2006
2	Conditioned Culture MediaIBA 01/2016 - 08/2006
2	rindopepimutIBA 06/2015 - 03/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 09/2014 - 04/2006
2	Granzymes (Granzyme)IBA 12/2013 - 09/2013
2	Lysine (L-Lysine)FDA Link 11/2013 - 10/2012

Therapy/Procedure

79	Therapeutics 01/2021 - 08/2003
30	Immunotherapy 01/2021 - 02/2002
22	Drug Therapy (Chemotherapy) 01/2019 - 01/2004
10	Radiotherapy 07/2013 - 06/2005
4	Radioimmunotherapy 05/2007 - 09/2005
3	Catheters 12/2018 - 02/2007
2	Chemoradiotherapy 01/2016 - 01/2011